In this quarterly strategy report, we look to evaluate where we are with regards the bull market conditions, and where those indicators might be headed, factoring in the downside risks, from Trump tariffs and the US economy, BoJ actions, Japanese earnings and valuations.
EQS-News: Olympus Corp. / Key word(s): Miscellaneous Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India 12.06.2024 / 14:30 CET/CEST The issuer is solely responsible for the content of this announcement. Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India Endoscopy Engineering support services in India Tokyo, Japan, 12 June 2024, JCN Newswire - Olympus Corporation (Olympus), a global MedTech Company committed to making people’s lives healthier, safer and more fulfilling, today announced its strategic initiative ...
Olympus (7733 JT) seems to be leaning into the market’s acceptance that FY23 is a write-off, reporting yet more expenses for Q4. This review includes management’s comments on how the firm plans to achieve an earnings recovery in FY24.
FY23 is proving to be a housecleaning year for Olympus, some of it undertaken proactively, such as the sale of the scientific instruments business, some of it reactively, such as recalls and write downs. Analyst Nia Dokova discusses the outlook.
Asset sale gains by Olympus in FY22 made it hard for FY23 to look good anyway, but a procession of problems has turned a difficult situation into a bad one. However, with most of the issues being one-offs, a recovery in earnings is expected in FY24. With the shares down -30% from their peak, it may be time to revisit the stock.
OLYMPUS (JP), a company active in the Medical Equipment industry, sees its general evaluation downgraded to Neutral on account of a double requalification. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour has also deteriorated and is evaluated as moderately risky. theScreener believes that the loss of a star(s) and the increased risk justifies the general evaluation downgrade, which passes to Neutral. As of the...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
HAMBOURG, Allemagne & TOKYO, Japon--(BUSINESS WIRE)-- Olympus Corporation (Président : Yasuo Takeuchi) a annoncé aujourd’hui la sortie de l’EVIS X1, son tout dernier système d’endoscopie. Ce nouveau système vise à améliorer les résultats associés aux troubles de l’estomac, du côlon et de l’œsophage, ainsi qu’aux maladies bronchiques, en fournissant à tous les endoscopistes des outils innovants ayant fait leurs preuves. Le lancement de l’EVIS X1 vient renforcer le leadership d’Olympus dans le domaine de l’endoscopie et marquer son empreinte dans le secteur médical. Ce communiqué de presse conti...
Japan Market Comment by Julie Boote, Joel Scheiman and Thao Nguyen Nikkei ¥21,181.64 (-¥542.83 / -2.50%); Topix ¥1,708.34 (-¥31.86 / -1.83%); ¥/$105.85 Tags: Nippon Steel & Sumitomo Metal Corp (5401 JP), JFE Holdings (5411 JP), Kobe Steel (5406 JP), Nisshin Steel (5413 JP), Yamato Kogyo (5444 JP), Olympus (7733 JP), Hoya (7741 JP), Chugai Pharma (4519 JP), Tokai Carbon (5301 JP), Sumco (3436 JP), Isuzu Motors (7202 JP), Toyota (7203 JP), Honda (7267 JP), Subaru (7270 JP), Nissan (7201 JP),...
Main Points• FY17 Q3 saw yet another revision up to the full year earnings…• …but the new forecasts continue to look conservative.• We show the Sum of the Parts valuation on an EV/OP basis, both with and without Financials;• There are also “other adjustments” to consider, which include holdings in M3 Japan (2413 JP) and Olympus (7733 JP), that will affect Sony’s EV/OP; • And finally, we attempt to value Sony’s Contents Business.• Our Sum of the Parts analysis demonstrates that Sony is worth subs...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.